The systemic vasculitides are a group of potentially life-threatening multi-system autoimmune connective tissue diseases characterized by vascular inflammation. The gold standard therapies include corticosteroids and cyclophosphamide as induction therapy and other agents such as azathioprine and methotrexate to maintain remission. Mycophenolate mofetil (MMF) is increasingly being used in autoimmune disorders and this article reviews the use of this agent in the systemic vasculitides.
JayneD, RasmussenN, AndrassyKEuropean Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med2003; 349: 36–44.
5.
LangfordCA, Talar-WilliamsC, SnellerMC.Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Longterm renal outcome in patients with glomerulonephritis. Arthritis Rheum2000; 43: 1836–1840.
6.
NowackR, GobelU, KlookerP, HergesellO, AndrassyK, van der WoudeFJ.Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol1999; 10: 1965–1971.
7.
LangfordCA, Talar-WilliamsC, SnellerMC.Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum2004; 51: 278–283.
8.
WaiserJ, BuddeK, BraaschE, NeumayerHH.Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil. Am J Kidney Dis1999; 34: e9.
9.
NeumannI, HaidingerM, JagerHPharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients. J Am Soc Nephrol2003; 14: 721–727.
10.
HaubitzM, de GrootK.Tolerance of mycophenolate mofetil in endstage renal disease patients with ANCA-associated vasculitis. Clin Nephrol2002; 57: 421–424.
11.
WoywodtA, ChoiM, SchneiderW, KettritzR, GobelU.Cytomegalovirus colitis during mycophenolate mofetil therapy for Wegener's granulomatosis. Am J Nephrol2000; 20: 468–472.
12.
DainaE, SchieppatiA, RemuzziG.Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med1999; 130: 422–426.
13.
AdlerYD, MansmannU, ZouboulisCC.Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behcet's disease. Dermatology2001; 203: 322–324.
